Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction-Reference-Cited by-同舟云学术

Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction

Published:2011-12 Issue:12 Volume:13 Page:1283-1289
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Timmer Stefan A.J.¹,Germans Tjeerd¹,Brouwer Wessel P.¹,Lubberink Mark²,van der Velden Jolanda¹,Wilde Arthur A.M.³,Christiaans Imke³,Lammertsma Adriaan A.²,Knaapen Paul¹,van Rossum Albert C.¹

Affiliation:

1. Department of Cardiology, 5F; VU University Medical Center; De Boelelaan 1117, 1081 HV Amsterdam The Netherlands

2. Department of Nuclear Medicine & PET Research; VU University Medical Center; Amsterdam The Netherlands

3. Department of Cardiology; Amsterdam University Medical Center; Amsterdam The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfr135/fullpdf

Reference41 articles.

1. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms;Seidman;Cell,2001

2. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy;Cecchi;N Eng J Med,2003

3. Mechanical efficiency in hypertrophic cardiomyopathy assessed by positron emission tomography with carbon 11 acetate;Ishiwata;Am Heart J,1997

4. Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy;Timmer;Eur J Nucl Med,2010

5. Myocardial metabolic changes in hypertrophic cardiomyopathy;Tadamura;J Nucl Med,1996

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease;Circulation: Genomic and Precision Medicine;2024-08

2. Myocardial contractility characteristics of hypertrophic cardiomyopathy patients with and without sarcomere mutation;Heart and Vessels;2024-05-28

3. Injectable, stretchable, and conductance-stable fiber for myocardial infarction repair;Composites Part B: Engineering;2024-03

4. FGF12 Modulates Cardiomyocyte Hypertrophy by Inhibiting GATA4-ERK1/2 Phosphorylation Through Altered Intracellular Localization;2023-12-22

5. Hypertrophic cardiomyopathy - phenotypic variations beyond wall thickness;Clinical Imaging;2023-03